Last reviewed · How we verify
cyclosporine 0.05% ophthalmic emulsion — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
cyclosporine 0.05% ophthalmic emulsion (cyclosporine 0.05% ophthalmic emulsion) — Allergan.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| cyclosporine 0.05% ophthalmic emulsion TARGET | cyclosporine 0.05% ophthalmic emulsion | Allergan | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- cyclosporine 0.05% ophthalmic emulsion CI watch — RSS
- cyclosporine 0.05% ophthalmic emulsion CI watch — Atom
- cyclosporine 0.05% ophthalmic emulsion CI watch — JSON
- cyclosporine 0.05% ophthalmic emulsion alone — RSS
Cite this brief
Drug Landscape (2026). cyclosporine 0.05% ophthalmic emulsion — Competitive Intelligence Brief. https://druglandscape.com/ci/cyclosporine-0-05-ophthalmic-emulsion. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab